Peptide Industry intermediate
Peptide Generic Market
The landscape of generic and biosimilar peptide therapeutics.
By Encyclopeptide Editorial | 1 min read
generics biosimilars market competition
Overview
The peptide generic market is expanding as patents expire on blockbuster peptide drugs, creating opportunities for manufacturers.
Key Segments
- Insulin analogs: Major generic opportunity
- GnRH agonists: Established generic market
- GLP-1 agonists: Emerging biosimilar competition
- Calcitonin: Mature generic market
Regulatory Pathways
- ANDA pathway for peptide generics in the US
- Biosimilar framework for larger peptides
- Hybrid applications in Europe
- Reference product comparability studies
Challenges
Demonstrating bioequivalence, managing immunogenicity, and competing on cost while maintaining quality.
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Generic Market with interactive quizzes on Wikipept.
Take a Quiz on Wikipept